Hosted on MSN22d
Charles River falls after projecting 2025 revenue dropCharles River Laboratories (NYSE:CRL) lost ~12% in the premarket on Tuesday after the contract research organization said its 2025 revenue on an organic basis is expected to decline at a similar ...
In a report released on February 1, Casey Woodring from J.P. Morgan maintained a Hold rating on Charles River Labs (CRL – Research Report), ...
CRAI, as a relatively small player in the consulting and research services sector, presents a compelling narrative when evaluating its market position and growth potential. The company has carved ...
OptimX Markets has moved to expand its ability to offer institutional clients bilateral liquidity with a new integration with State Street’s order and execution platform, Charles River. As part of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results